Holden, Thomas
Vijayvergia, Namrata
Article History
Accepted: 26 December 2020
First Online: 16 January 2021
Compliance with Ethical Standards
:
: Namrata Vijayvergia has received consultancy fees from Lexicon, Novartis, HalioDx, and Sun Pharma and grants from Merck and Bayer. Thomas Holden declares that he has no conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.